Press Releases

Jim Flatt CEO DMC Biotechnologies Headshot_sqr

Dr. Jim Flatt Announced as New CEO of DMC Biotechnologies

MORRISVILLE, NC – January 14, 2025 – DMC Biotechnologies, a leader in synthetic biology and precision fermentation, is pleased to announce the appointment of Dr. James (Jim) Flatt as Chief Executive Officer, effective immediately. Dr. Flatt brings more than 30 years...
Doug Cameron Joins DMC Board of Directors

Doug Cameron Joins DMC Board of Directors

15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…

read more
DMC Completes Successful Pilot of L-alanine

DMC Completes Successful Pilot of L-alanine

15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…

read more